| Revision as of 18:14, 5 November 2007 editA. B. (talk | contribs)Extended confirmed users, Page movers, IP block exemptions, New page reviewers, Pending changes reviewers, Rollbackers51,784 edits add 7 references from reliable sources + company web site + Template:Finance links← Previous edit | Revision as of 18:19, 5 November 2007 edit undoA. B. (talk | contribs)Extended confirmed users, Page movers, IP block exemptions, New page reviewers, Pending changes reviewers, Rollbackers51,784 editsm →External links: fix templateNext edit → | ||
| Line 22: | Line 22: | ||
| | symbol = DOVP | | symbol = DOVP | ||
| | sec_cik = 0001066833 | | sec_cik = 0001066833 | ||
| | hoovers = |
| hoovers = 105507 | ||
| }} | }} | ||
Revision as of 18:19, 5 November 2007
| An editor has nominated this article for deletion. You are welcome to participate in the deletion discussion, which will decide whether or not to retain it.Feel free to improve the article, but do not remove this notice before the discussion is closed. For more information, see the guide to deletion. Find sources: "DOV Pharmaceutical" – news · newspapers · books · scholar · JSTOR%5B%5BWikipedia%3AArticles+for+deletion%2FDOV+Pharmaceutical%5D%5DAFD |
DOV Pharmaceutical, a biotechnology company, focuses on therapies primarily for central nervous system conditions. The firm's lead drug candidate, Indiplon, is said to treat insomnia. Indiplon targets the same subset of neurotransmitter receptors affected by Valium and Xanax, but with more specificity to avoid the side effects associated with those drugs. DOV Pharmaceutical, Neurocrine Biosciences, and Pfizer are working on the candidate. Other candidates in DOV's pipeline target depression and angina, pain, anxiety, high blood pressure, and other disorders.
References
- Hess, Diane, Drugmaker's IPO Is a Big Headache, TheStreet.com, 1 May 2002. Retrieved 5 November 2007.
- Simpson, Stephen D. A Pain DOV Pharmaceutical Couldn't Cure, Motley Fool, 26 April 2006. Retrieved 5 November 2007.
- Krauskopf, Lewis, Investors Suing Hackensack, N.J.-Based DOV Pharmaceutical over Stock Losses, The Record (Hackensack, New Jersey), 2 May 2002. Retrieved 5 November 2007.
- Lynn, Kathleen, Dov Pharmaceutical exploring alternatives, The Record (Hackensack, New Jersey), 11 October 2006. Retrieved 5 November 2007.
- Maeillo, Michael, The Coldest IPO..., Forbes.com, 2 September 2002. Retrieved 5 November 2007.
- DOV IPO sinks on first day, CNN.com, 25 April, 2002. Retrieved 5 November 2007.
- DOV Pharmaceutical Inc. (DOVP), Wall Street Journal profile. Retrieved 5 November 2007.
External links
- Business data for DOV Pharmaceutical Inc.:
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Misplaced Pages by expanding it. |